Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cilostazol Versus Aspirin for Secondary Prevention of Vascular Events After Stroke of Arterial Origin." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435757/all/Adjuvant_chemotherapy_for_endometrial_cancer_after_hysterectomy:_Cochrane_systematic_review. Accessed 23 April 2024.
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/all/Adjuvant_chemotherapy_for_endometrial_cancer_after_hysterectomy:_Cochrane_systematic_review. Accessed April 23, 2024.
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/all/Adjuvant_chemotherapy_for_endometrial_cancer_after_hysterectomy:_Cochrane_systematic_review
Cilostazol Versus Aspirin for Secondary Prevention of Vascular Events After Stroke of Arterial Origin [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/all/Adjuvant_chemotherapy_for_endometrial_cancer_after_hysterectomy:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin
ID - 435757
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/all/Adjuvant_chemotherapy_for_endometrial_cancer_after_hysterectomy:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -